Clinical Drug Trials for Parkinson’s Disease
Read about our clinical trials research program
For Patients with Early Parkinson's Disease who have not been treated or have been treated for 30 days or less:
Testing a new drug to see if it reduces the symptoms related to Parkinson's Disease
For Patients with Early Parkinson's Disease not being treated with any dopamine agonist:
Testing to see if retinal deterioration is present in patients treated with
pramipexole
versus
ropinirole
For Patients with Parkinson's Disease:
Testing the safety and efficacy of an investigational drug on psychosis associated with Parkinson's Disease.
If you are diagnosed with Parkinson’s Disease and are interested in knowing more about these clinical trials or other trials we may have in the future, please contact the clinical trials office:
Angel Figueroa
Research Worker
212.305.3938
af2161@columbia.edu
Anne Tam, CCRC
Clinical Trials Coordinator
212.305.6121
atam@neuro.columbia.edu
Home
|
Learn About
|
Clinical Care
|
Surgical Service
|
Faculty
|
Research
|
Clinical Research Studies
|
Genetic Counseling
|
Brain Bank
|
Cinical Motor Physiology
|
Contact Us
| ©2004-2008 The Neurological Institute of New York • At Columbia University Medical Center
Center for Parkinson Disease & Other Movement Disorders • 710 W 168th St, New York, NY 10032
Updated April 1, 2008 •
Comments
Read about our clinical trials research program